Clinical Schizophrenia & Related Psychoses

Google Scholar citation report

Citations : 6601

Clinical Schizophrenia & Related Psychoses received 6601 citations as per Google Scholar report

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

	2022	2021	2020	2019	2018
Year wise published articles	105	141	28	8	28
Year wise citations received	543	553	590	563	587

Journal total citations count	6601
Journal Impact Factor	6.49
Journal 5 years Impact Factor	12.17
Journal CiteScore	11.19
Journal h-index	41
Journal h-index since 2016	26

Liu, Fang, Liqin Xie, Bingkui Zhang, Ye Ruan, Yong Zeng, XiuFeng Xu, Jingping Zhao, and Xiaoduo Fan. "No effect of adjunctive minocycline treatment on body metabolism in patients with schizophrenia." Journal of clinical psychopharmacology 38, no. 2 (2018): 125-128. View at Publisher View at Google Scholar View at Indexing
Dempsey, Charles, Cameron Quanbeck, Clarissa Bush, and Kelly Kruger. "Decriminalizing mental illness: specialized policing responses." CNS spectrums 25, no. 2 (2020): 181-195. View at Publisher View at Google Scholar View at Indexing
das Neves Duarte, Joao Miguel, Anita Kulak, Mehdi Mohammad Gholam-Razaee, Michel Cuenod, Rolf Gruetter, and Kim Quang Do. "N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development." Biological psychiatry 71, no. 11 (2012): 1006-1014. View at Publisher View at Google Scholar View at Indexing
García Ullán, Llanyra. "Conciencia de enfermedad y adherencia terapéutica en el paciente psicótico." (2015). View at Publisher View at Google Scholar View at Indexing
Chowdhury, Golam MI, Kevin L. Behar, William Cho, Monique A. Thomas, Douglas L. Rothman, and Gerard Sanacora. "1H-[13C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism." Biological psychiatry 71, no. 11 (2012): 1022-1025. View at Publisher View at Google Scholar View at Indexing
Gerretsen, Philip, Aristotle N. Voineskos, Ariel Graff-Guerrero, Mahesh Menon, Bruce G. Pollock, David C. Mamo, Benoit H. Mulsant, and Tarek K. Rajji. "Insight into illness and cognition in schizophrenia in earlier and later life." The Journal of clinical psychiatry 78, no. 4 (2017): 0-0. View at Publisher View at Google Scholar View at Indexing
Miller, Brian J., and Peter F. Buckley. "Is relapse in schizophrenia an immune-mediated effect?." Focus 10, no. 2 (2012): 115-123. View at Publisher View at Google Scholar View at Indexing
Phahladira, Lebogang, Laila Asmal, Sanja Kilian, Bonginkosi Chiliza, Frederika Scheffler, Hilmar K. Luckhoff, Stefan du Plessis, and Robin Emsley. "Changes in insight over the first 24 months of treatment in schizophrenia spectrum disorders." Schizophrenia research 206 (2019): 394-399. View at Publisher View at Google Scholar View at Indexing
Alberati, Daniela, Jean-Luc Moreau, Judith Lengyel, Nicole Hauser, Roland Mory, Edilio Borroni, Emmanuel Pinard et al. "Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia." Neuropharmacology 62, no. 2 (2012): 1152-1161. View at Publisher View at Google Scholar View at Indexing
Volavka, Jan. "Clozapine is gold standard, but questions remain." International Journal of Neuropsychopharmacology 15, no. 9 (2012): 1201-1204. View at Publisher View at Google Scholar View at Indexing
Silverstein, Steven M., and Richard Rosen. "Schizophrenia and the eye." Schizophrenia Research: Cognition 2, no. 2 (2015): 46-55. View at Publisher View at Google Scholar View at Indexing
Nimgaonkar, Vishwajit L., Faith Dickerson, Jennie G. Pouget, Kodavali Chowdari, Colm O’Dushlaine, Joel Wood, Lambertus Klei, Bernie Devlin, and Robert Yolken. "Joint evaluation of serum C-reactive protein levels and polygenic risk scores as risk factors for schizophrenia." Psychiatry research 261 (2018): 148-153. View at Publisher View at Google Scholar View at Indexing
Ermel, Julia, Cameron S. Carter, James M. Gold, Angus W. MacDonald III, J. Daniel Ragland, Steven M. Silverstein, Milton E. Strauss, and Deanna M. Barch. "Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder." Schizophrenia research: cognition 9 (2017): 1-7. View at Publisher View at Google Scholar View at Indexing
Pocivavsek, Ana, Hui-Qiu Wu, Michelle C. Potter, Greg I. Elmer, Roberto Pellicciari, and Robert Schwarcz. "Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory." Neuropsychopharmacology 36, no. 11 (2011): 2357-2367. View at Publisher View at Google Scholar View at Indexing
Crespo-Facorro, Benedicto, Jose Maria Pelayo-Teran, and Jacqueline Mayoral-van Son. "Current data on and clinical insights into the treatment of first episode nonaffective psychosis: a comprehensive review." Neurology and therapy 5, no. 2 (2016): 105-130. View at Publisher View at Google Scholar View at Indexing
Varun, Chakrakodi N., Ravikumar Raju, Manjunatha M. Venkataswamy, Vasanthapuram Ravi, and Shivarama Varambally. "Procalcitonin and C-reactive protein as peripheral inflammatory markers in antipsychotic drug-free schizophrenia patients." Asian journal of psychiatry 35 (2018): 11-14. View at Publisher View at Google Scholar View at Indexing
Kantrowitz, Joshua, and Daniel C. Javitt. "Glutamatergic transmission in schizophrenia: from basic research to clinical practice." Current opinion in psychiatry 25, no. 2 (2012): 96. View at Publisher View at Google Scholar View at Indexing
Cobo, Jesus, Lourdes Nieto, Susana Ochoa, Esther Pousa, Judith Usall, Iris Baños, Beatriz González, Isabel Ruiz, Ada I. Ruiz, and Insight Barcelona Research Group. "Insight and gender in schizophrenia and other psychoses." Psychiatry research 243 (2016): 268-277. View at Publisher View at Google Scholar View at Indexing
Murru, A., I. Pacchiarotti, A. M. A. Nivoli, C. M. Bonnin, B. Patrizi, B. Amann, E. Vieta, and F. Colom. "Rates and clinical correlates of treatment non?adherence in schizoaffective bipolar patients." Acta psychiatrica scandinavica 125, no. 5 (2012): 412-418. View at Publisher View at Google Scholar View at Indexing
Weickert, C. Shannon, S. J. Fung, V. S. Catts, P. R. Schofield, K. M. Allen, L. T. Moore, Kelly A. Newell et al. "Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia." Molecular psychiatry 18, no. 11 (2013): 1185-1192. View at Publisher View at Google Scholar View at Indexing
Prev 1 2 ... 34 35 36 37 38 39 40 41 42 43 44 ... 84 85 Next »

Google Scholar citation report

Citations : 6601

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In

PMC/PubMed Indexed Articles

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Liu, Fang, Liqin Xie, Bingkui Zhang, Ye Ruan, Yong Zeng, XiuFeng Xu, Jingping Zhao, and Xiaoduo Fan. "No effect of adjunctive minocycline treatment on body metabolism in patients with schizophrenia." Journal of clinical psychopharmacology 38, no. 2 (2018): 125-128.

Dempsey, Charles, Cameron Quanbeck, Clarissa Bush, and Kelly Kruger. "Decriminalizing mental illness: specialized policing responses." CNS spectrums 25, no. 2 (2020): 181-195.

García Ullán, Llanyra. "Conciencia de enfermedad y adherencia terapéutica en el paciente psicótico." (2015).

Chowdhury, Golam MI, Kevin L. Behar, William Cho, Monique A. Thomas, Douglas L. Rothman, and Gerard Sanacora. "1H-[13C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism." Biological psychiatry 71, no. 11 (2012): 1022-1025.

Gerretsen, Philip, Aristotle N. Voineskos, Ariel Graff-Guerrero, Mahesh Menon, Bruce G. Pollock, David C. Mamo, Benoit H. Mulsant, and Tarek K. Rajji. "Insight into illness and cognition in schizophrenia in earlier and later life." The Journal of clinical psychiatry 78, no. 4 (2017): 0-0.

Miller, Brian J., and Peter F. Buckley. "Is relapse in schizophrenia an immune-mediated effect?." Focus 10, no. 2 (2012): 115-123.

Phahladira, Lebogang, Laila Asmal, Sanja Kilian, Bonginkosi Chiliza, Frederika Scheffler, Hilmar K. Luckhoff, Stefan du Plessis, and Robin Emsley. "Changes in insight over the first 24 months of treatment in schizophrenia spectrum disorders." Schizophrenia research 206 (2019): 394-399.

Alberati, Daniela, Jean-Luc Moreau, Judith Lengyel, Nicole Hauser, Roland Mory, Edilio Borroni, Emmanuel Pinard et al. "Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia." Neuropharmacology 62, no. 2 (2012): 1152-1161.

Volavka, Jan. "Clozapine is gold standard, but questions remain." International Journal of Neuropsychopharmacology 15, no. 9 (2012): 1201-1204.

Silverstein, Steven M., and Richard Rosen. "Schizophrenia and the eye." Schizophrenia Research: Cognition 2, no. 2 (2015): 46-55.

Pocivavsek, Ana, Hui-Qiu Wu, Michelle C. Potter, Greg I. Elmer, Roberto Pellicciari, and Robert Schwarcz. "Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory." Neuropsychopharmacology 36, no. 11 (2011): 2357-2367.

Crespo-Facorro, Benedicto, Jose Maria Pelayo-Teran, and Jacqueline Mayoral-van Son. "Current data on and clinical insights into the treatment of first episode nonaffective psychosis: a comprehensive review." Neurology and therapy 5, no. 2 (2016): 105-130.

Varun, Chakrakodi N., Ravikumar Raju, Manjunatha M. Venkataswamy, Vasanthapuram Ravi, and Shivarama Varambally. "Procalcitonin and C-reactive protein as peripheral inflammatory markers in antipsychotic drug-free schizophrenia patients." Asian journal of psychiatry 35 (2018): 11-14.

Kantrowitz, Joshua, and Daniel C. Javitt. "Glutamatergic transmission in schizophrenia: from basic research to clinical practice." Current opinion in psychiatry 25, no. 2 (2012): 96.

Cobo, Jesus, Lourdes Nieto, Susana Ochoa, Esther Pousa, Judith Usall, Iris Baños, Beatriz González, Isabel Ruiz, Ada I. Ruiz, and Insight Barcelona Research Group. "Insight and gender in schizophrenia and other psychoses." Psychiatry research 243 (2016): 268-277.

Murru, A., I. Pacchiarotti, A. M. A. Nivoli, C. M. Bonnin, B. Patrizi, B. Amann, E. Vieta, and F. Colom. "Rates and clinical correlates of treatment non?adherence in schizoaffective bipolar patients." Acta psychiatrica scandinavica 125, no. 5 (2012): 412-418.

Weickert, C. Shannon, S. J. Fung, V. S. Catts, P. R. Schofield, K. M. Allen, L. T. Moore, Kelly A. Newell et al. "Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia." Molecular psychiatry 18, no. 11 (2013): 1185-1192.